Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Eucalyptus has a long history of traditional use for respiratory ailments, but its use for influenza is also supported by some scientific evidence, albeit limited. The primary active component in eucalyptus oil, eucalyptol (1,8-cineole), has demonstrated antiviral, anti-inflammatory, and mucolytic properties in laboratory studies. Some in vitro studies suggest that eucalyptus oil and its constituents may inhibit viral replication, including that of influenza viruses. However, the majority of these studies are preclinical, and robust clinical trials in humans specifically addressing influenza are lacking.

In practice, eucalyptus is most commonly used as an inhalant or in lozenges to help alleviate symptoms such as cough, congestion, and sore throat. Its mechanism of action appears to be more about symptom relief—through reducing airway inflammation and loosening mucus—rather than directly targeting the influenza virus itself. Some clinical studies have shown benefit in upper respiratory tract infections, but these are often not specific to laboratory-confirmed influenza.

In summary, while there is some scientific rationale for the use of eucalyptus to help with certain symptoms of influenza, the evidence for its effectiveness against the virus itself is weak. Its use is better justified for symptomatic relief rather than as a direct antiviral therapy. More rigorous, targeted clinical trials are needed to establish its efficacy for influenza specifically.

More about eucalyptus
More about Influenza

Other ingredients used for Influenza

Other health conditions supported by eucalyptus

Products containing eucalyptus